Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease

BACKGROUND: Coronavirus disease 2019 (COVID-19) infection is known to cause abnormal hepatic enzymes. The long term consequences of such elevations are uncertain. AIM: To assessed the prevalence and prognostic value of initial liver enzymes in a large cohort of COVID-19 patients. METHODS: We reviewe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstein, David, Roth, Nitzan, Kim, Angela, Epstein, Marica, Hirschwerk, David, Kvasnovsky, Charlotte L, Satapathy, Sanjaya K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611205/
https://www.ncbi.nlm.nih.gov/pubmed/34876794
http://dx.doi.org/10.3748/wjg.v27.i42.7350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611205/
https://www.ncbi.nlm.nih.gov/pubmed/34876794
http://dx.doi.org/10.3748/wjg.v27.i42.7350

Ejemplares similares